Recently, it has been demonstrated that toll-like receptors (TLRs) can cause tumor development and progression by orchestrating cellular signaling pathways such as NF-κB signaling, Src/MAPK signaling, Wnt signaling, and phosphoinositide-3 kinase (PI3K)/Akt signaling [4–8]. This evidence concerns the gene AKT1 and neoplasm.